
BI 764524 was well tolerated following intravitreal administration of single and multiple doses in the phase 1/2a trial, with signs pointing to early efficacy.

BI 764524 was well tolerated following intravitreal administration of single and multiple doses in the phase 1/2a trial, with signs pointing to early efficacy.

McIntyre explains why GLP-1/GIP receptor agonists like semaglutide may alter cognitive and psychiatric care similar to cardiometabolic disease.

Devanand reviews lecanemab and the advent of blood biomarkers for dementia and Alzheimer's management at APA 2024.

Kane explains why newer long-acting injectables and clozapine may be under-utilized still in the management of schizophrenia.

Despite often presenting to the hospital with similar non-psychiatric conditions, patients with schizophrenia often experience a more difficult care process than those without.

New literature review data suggests doxazosin is related to less incident hypotension than prazosin, while providing clinical benefit, in PTSD patients with condition-related nightmares.

Four-year, phase 3 data from APA 2024 show olanzapine/samidorphan provided consistent antipsychotic efficacy and weight-related safety in patients with either schizophrenia or bipolar I disorder.

During this discussion, Ohuabunwa discussed additional takeaways from her ACP conference talk on postdischarge care and other tips for internal medicine physicians.

This discussion with Ohuabunwa was held at the ACP conference and covered inpatient geriatrics assessment tips for internal medicine physicians.

Matthew Nudy, MD, discusses a trio of meta-analyses examining the effects of intensive blood pressure control on various targets.

Chun spoke in this interview segment about more recommendations for internal medicine physicians to give older adults related to aging, dementia, and statin use.

Solomon discusses the health care system’s role in mitigating climate change and how health care professionals can help protect and inform their patients.

In this interview, Chun discussed recommendations for internal medicine physicians to give older adults for slowing aging as well as evidence for statins.

Solomon explains how the health care system contributes to climate change and the direct health impacts seen as a result, based on her session at ACP.

This segment of Hemming’s ACP interview featured a discussion of a website used to assess digital applications for patients struggling with mental health issues.

Branch provides an overview of the use of dual antiplatelet therapy and anticoagulants based on his session at the ACP Internal Medicine meeting.

Another segment of her ACP 2024 interview featured a discussion on weight loss drugs, healthy living, and discussions with patients.

Shah discusses the prevalence of psychiatric illness among hospitalized patients and highlights key considerations for their management from her session at ACP.

Nahas reviews key highlights from her session at ACP, emphasizing the importance of reviewing patient history and considering what other factors may be causing headaches.

Branch discusses key takeaways from his session at ACP and guideline recommendations for primary and secondary prevention of cardiovascular disease.

Thorndike discussed highlights from her ACP 2024 talk titled ‘Annals Beyond the Guidelines: How Would You Treat this Patient with Obesity?’

Contrary to previous research, findings point to similar decreases in weight and improvements in glucose homeostasis between time-restricted eating and usual eating pattern groups.

In this segment of his interview, Leff described what he hopes internal medicine physicians viewing his talk walk away realizing about Hospital at Home.

At the ACP Internal Medicine Meeting, Leff described the outcomes and implementation of the ‘Hospital at Home’ program for elderly adults.

Data presented at ACP 2024 shows non-White patients may be particularly subjected to more risk of discrimination in their care when ED boarding extends past 24 hours.

This discussion with Hemming featured the biggest takeaways from his talk titled ‘Depression and Anxiety Treatment by the Internal Medicine Physician.’

Markland discusses the use of anticholinergics, beta 3-agonists, and nonpharmacologic treatments for urge urinary incontinence, based on her session at ACP.

Wilt discusses the different screening methods recommended by ACP and explains how he talks about screening with his patients.

This interview at ACP 2024 featured a discussion with Hemming on the Mental Health Care Model (MHCM) and addressing depression in primary care settings.

This presentation at ACP Internal Medicine 2024 covered key skills Colven believes internists should know for identification of dermatologic conditions.